InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,710.00
(
0.16%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.21
(
1.00%
)
Bitcoin
62,858.15
(
2.30%
)
Post# of 1721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 898
Posts 148978
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: RobotDroid post# 1362

Friday, 07/20/2018 10:53:51 AM

Friday, July 20, 2018 10:53:51 AM

Post# of 1721
$INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen $MYL https://globenewswire.com/news-release/2017/12/07/1247514/0/en/INSYS-Therapeutics-Starts-Proof-of-Concept-Study-of-Epinephrine-Nasal-Spray-for-Anaphylaxis.html

****In May 2018 FDA declared an EpiPen shortage across much of country. https://www.cbsnews.com/news/epipen-shortage-2018-05-09-fda/

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up